| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |